Tai Ching Ho

Tai Ching Ho

No más puestos en curso
64 años
Health Technology
Consumer Services
Commercial Services

Perfil

Tai Ching Ho is the founder of two companies.
He founded BeiGene Ltd. in 2010 and served as President from 2010 to 2012.
He also founded Metastagen, Inc. in 2013 and served as Chief Executive Officer from 2013 to 2014.
Dr. Ho held several former jobs, including Vice President-Oncology Development at Johnson & Johnson from 2008 to 2010, Chief Medical Officer & Executive Vice President at Epizyme, Inc. from 2015 to 2017, and Senior Vice President-Oncology Center at GlaxoSmithKline LLC.
He was also Chief Medical Officer at Boston Pharmaceuticals, Inc. from 2018 to 2020 and Independent Director at Aravive, Inc. from 2021 to 2024.
Dr. Ho received his undergraduate degree from The Johns Hopkins University and his doctorate from Yale School of Medicine.

Antiguos cargos conocidos de Tai Ching Ho.

EmpresasCargoFin
ARAVIVE, INC. Director/Miembro de la Junta 17/01/2024
Director Técnico/Científico/I+D 01/01/2020
EPIZYME, INC. Director Técnico/Científico/I+D 31/12/2017
Director Ejecutivo 01/09/2014
BEIGENE LTD Fundador 01/12/2012
Ver el detalle de la experiencia de Tai Ching Ho.

Formación de Tai Ching Ho.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

46

Relaciones de 1er grado

9

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas9

Health Technology

Consumer Services

Health Technology

Health Technology

Consumer Services

Health Technology

Commercial Services

Health Technology

Health Technology